Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1981 Mar 1;153(3):694–705. doi: 10.1084/jem.153.3.694

Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 streptococcus pneumoniae

PMCID: PMC2186108  PMID: 7252411

Abstract

The antiphosphocholine (PC) antibody in normal mouse sera (NMS) provides protection against intravenous infection with encapsulated strain WU2 of type 3 Streptococcus pneumoniae. Mice unable to make anti- PC antibody, as a result of suppression with anti-T-15 idiotype or inheritance of the xid gene of CAB/N mice, are highly susceptible to infection with strain WU2. Mice inheriting the xid gene can be protected with NMS from immunologically normal mice or with IgM hybridoma anti-PC antibody. The protective effect of NMS can be removed with PC-containing immunoabsorbents.

Full Text

The Full Text of this article is available as a PDF (881.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amsbaugh D. F., Hansen C. T., Prescott B., Stashak P. W., Asofsky R., Baker P. J. Genetic control of the antibody response to type 3 pneumococcal polysaccharide in mice. II. Relationship between IgM immunoglobulin levels and the ability to give an IgM antibody response. J Exp Med. 1974 Jun 1;139(6):1499–1512. doi: 10.1084/jem.139.6.1499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Amsbaugh D. F., Hansen C. T., Prescott B., Stashak P. W., Barthold D. R., Baker P. J. Genetic control of the antibody response to type 3 pneumococcal polysaccharide in mice. I. Evidence that an X-linked gene plays a decisive role in determining responsiveness. J Exp Med. 1972 Oct 1;136(4):931–949. doi: 10.1084/jem.136.4.931. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Augustin A., Cosenza H. Expression of new idiotypes following neonatal idiotypic suppression of a dominant clone. Eur J Immunol. 1976 Jul;6(7):497–501. doi: 10.1002/eji.1830060710. [DOI] [PubMed] [Google Scholar]
  4. Austrian R. Pneumococcal vaccine: development and prospects. Am J Med. 1979 Oct;67(4):547–549. doi: 10.1016/0002-9343(79)90222-5. [DOI] [PubMed] [Google Scholar]
  5. Avery O. T., Macleod C. M., McCarty M. STUDIES ON THE CHEMICAL NATURE OF THE SUBSTANCE INDUCING TRANSFORMATION OF PNEUMOCOCCAL TYPES : INDUCTION OF TRANSFORMATION BY A DESOXYRIBONUCLEIC ACID FRACTION ISOLATED FROM PNEUMOCOCCUS TYPE III. J Exp Med. 1944 Feb 1;79(2):137–158. doi: 10.1084/jem.79.2.137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Benca R., Quintáns J., Kearney J. F., Flood P. M., Schreiber H. Studies on phosphorylcholine-specific T cell idiotypes and idiotype-specific immunity. Mol Immunol. 1980 Jul;17(7):823–831. doi: 10.1016/0161-5890(80)90031-0. [DOI] [PubMed] [Google Scholar]
  7. Berek C., Schreier M. H., Sidman C. L., Jaton J. C., Kocher H. P., Cosenza H. Phosphorylcholine-binding hybridoma proteins of normal and idiotypically suppressed BALB/c mice I. Characterization and idiotypic analysis. Eur J Immunol. 1980 Apr;10(4):258–263. doi: 10.1002/eji.1830100407. [DOI] [PubMed] [Google Scholar]
  8. Bornstein D. L., Schiffman G., Bernheimer H. P., Austrian R. Capsulation of pneumococcus with soluble C-like (Cs) polysaccharide. I. Biological and genetic properties of Cs pneumococcal strains. J Exp Med. 1968 Dec 1;128(6):1385–1400. doi: 10.1084/jem.128.6.1385. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Braley H. C., Freeman M. J. Strain differences in the antibody plaque-forming cell responses of inbred mice to pneumococcal polysaccharide. Cell Immunol. 1971 Feb;2(1):73–81. doi: 10.1016/0008-8749(71)90026-8. [DOI] [PubMed] [Google Scholar]
  10. Briles D. E., Perlmutter R. M., Hansburg D., Little J. R., Davie J. M. Immune response deficiency of BSVS mice. II. Generalized deficiency to thymus-dependent antigens. Eur J Immunol. 1979 Apr;9(4):255–261. doi: 10.1002/eji.1830090402. [DOI] [PubMed] [Google Scholar]
  11. Briles E. B., Tomasz A. Pneumococcal Forssman antigen. A choline-containing lipoteichoic acid. J Biol Chem. 1973 Sep 25;248(18):6394–6397. [PubMed] [Google Scholar]
  12. Brown A. R., Crandall C. A. A phosphorylcholine idiotype related to TEPC 15 in mice infected with Ascaris suum. J Immunol. 1976 Apr;116(4):1105–1109. [PubMed] [Google Scholar]
  13. Brown A. R., Crandall C. A. A phosphorylcholine idiotype related to TEPC 15 in mice infected with Ascaris suum. J Immunol. 1976 Apr;116(4):1105–1109. [PubMed] [Google Scholar]
  14. Brundish D. E., Baddiley J. Pneumococcal C-substance, a ribitol teichoic acid containing choline phosphate. Biochem J. 1968 Dec;110(3):573–582. doi: 10.1042/bj1100573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Chesebro B., Metzger H. Affinity labeling of a phosphorylcholine binding mouse myeloma protein. Biochemistry. 1972 Feb 29;11(5):766–771. doi: 10.1021/bi00755a014. [DOI] [PubMed] [Google Scholar]
  16. Claflin J. L. Clonal nature of the immune response to phosphorylcholine. VIII. Evidence that antibodies bearing T15 idiotypic determinants in Ighj mice comprise a family of antibodies. J Immunol. 1980 Aug;125(2):559–563. [PubMed] [Google Scholar]
  17. Claflin J. L., Davie J. M. Clonal nature of the immune response to phosphorylcholine. III. Species-specific binding characteristics of rodent anti-phosphorylcholine antibodies. J Immunol. 1974 Dec;113(6):1678–1684. [PubMed] [Google Scholar]
  18. Claflin J. L., Davie J. M. Clonal nature of the immune response to phosphorylcholine. IV. Idiotypic uniformity of binding site-associated antigenic determinants among mouse antiphosphorylcholine antibodies. J Exp Med. 1974 Sep 1;140(3):673–686. doi: 10.1084/jem.140.3.673. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Claflin J. L., Lieberman R., Davie J. M. Clonal nature of the immune response to phosphorylcholine. I. Specificity, class, and idiotype of phosphorylcholine-binding receptors on lymphoid cells. J Exp Med. 1974 Jan 1;139(1):58–73. doi: 10.1084/jem.139.1.58. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Claflin J. L., Lieberman R., Davie J. M. Clonal nature of the immune response to phosphorylcholine. II. Idiotypic specificity and binding characteristics of anti-phosphorylcholine antibodies. J Immunol. 1974 May;112(5):1747–1756. [PubMed] [Google Scholar]
  21. Claflin J. L. Uniformity in the clonal repertoire for the immune response to phosphorylcholine in mice. Eur J Immunol. 1976 Oct;6(10):669–674. doi: 10.1002/eji.1830061002. [DOI] [PubMed] [Google Scholar]
  22. Cosenza H., Köhler H. Specific inhibition of plaque formation to phosphorylcholine by antibody against antibody. Science. 1972 Jun 2;176(4038):1027–1029. doi: 10.1126/science.176.4038.1027. [DOI] [PubMed] [Google Scholar]
  23. Dubos R. J. IMMUNIZATION OF EXPERIMENTAL ANIMALS WITH A SOLUBLE ANTIGEN EXTRACTED FROM PNEUMOCOCCI. J Exp Med. 1938 Apr 30;67(5):799–808. doi: 10.1084/jem.67.5.799. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Dubos R. J. THE EFFECT OF FORMALDEHYDE ON PNEUMOCOCCI. J Exp Med. 1938 Feb 28;67(3):389–398. doi: 10.1084/jem.67.3.389. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Fernandez C., Möller G. Immunological unresponsiveness to thymus-independent antigens: two fundamentally different genetic mechanisms of B-cell unresponsiveness to dextran. J Exp Med. 1977 Dec 1;146(6):1663–1677. doi: 10.1084/jem.146.6.1663. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Goodner K., Horsfall F. L. THE PROTECTIVE ACTION OF TYPE I ANTIPNEUMOCOCCUS SERUM IN MICE : I. THE QUANTITATIVE ASPECTS OF THE MOUSE PROTECTION TEST. J Exp Med. 1935 Aug 31;62(3):359–374. doi: 10.1084/jem.62.3.359. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Hunter K. W., Jr, Finkelman F. D., Strickland G. T., Sayles P. C., Scher I. Defective resistance to Plasmodium yoelii in CBA/N mice. J Immunol. 1979 Jul;123(1):133–137. [PubMed] [Google Scholar]
  28. Janeway C. A., Jr, Barthold D. R. An analysis of the defective response of CBA/N mice to T-dependent antigens. J Immunol. 1975 Oct;115(4):898–900. [PubMed] [Google Scholar]
  29. Jones J. M., Amsbaugh D. F., Stashak P. W., Prescott B., Baker P. J., Alling D. W. Kinetics of the antibody response to type III pneumococcal polysaccharide. I. Evidence that suppressor cells function by inhibiting the recruitment and proliferation of antibody-producing cells. J Immunol. 1976 Mar;116(3):647–656. [PubMed] [Google Scholar]
  30. Lancefield R. C. A SEROLOGICAL DIFFERENTIATION OF HUMAN AND OTHER GROUPS OF HEMOLYTIC STREPTOCOCCI. J Exp Med. 1933 Mar 31;57(4):571–595. doi: 10.1084/jem.57.4.571. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Leon M. A., Young N. M. Specificity for phosphorylcholine of six murine myeloma proteins reactive with Pneumococcus C polysaccharide and beta-lipoprotein. Biochemistry. 1971 Apr 13;10(8):1424–1429. doi: 10.1021/bi00784a024. [DOI] [PubMed] [Google Scholar]
  32. Levitt D., Cooper M. D. Mouse pre-B cells synthesize and secrete mu heavy chains but not light chains. Cell. 1980 Mar;19(3):617–625. doi: 10.1016/s0092-8674(80)80038-9. [DOI] [PubMed] [Google Scholar]
  33. Lieberman R., Potter M., Mushinski E. B., Humphrey W., Jr, Rudikoff S. Genetics of a new IgVH (T15 idiotype) marker in the mouse regulating natural antibody to phosphorylcholine. J Exp Med. 1974 Apr 1;139(4):983–1001. doi: 10.1084/jem.139.4.983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Macleod C. M., Hodges R. G., Heidelberger M., Bernhard W. G. PREVENTION OF PNEUMOCOCCAL PNEUMONIA BY IMMUNIZATION WITH SPECIFIC CAPSULAR POLYSACCHARIDES. J Exp Med. 1945 Nov 30;82(6):445–465. [PMC free article] [PubMed] [Google Scholar]
  35. Mond J. J., Lieberman R., Inman J. K., Mosier D. E., Paul W. E. Inability of mice with a defect in B-lymphocyte maturation to respond to phosphorycholine on immunogenic carriers. J Exp Med. 1977 Oct 1;146(4):1138–1142. doi: 10.1084/jem.146.4.1138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Mosier D. E., Zitron I. M., Mond J. J., Ahmed A., Scher I., Paul W. E. Surface immunoglobulin D as a functional receptor for a subclass of B lymphocytes. Immunol Rev. 1977;37:89–104. doi: 10.1111/j.1600-065x.1977.tb00246.x. [DOI] [PubMed] [Google Scholar]
  37. O'Brien A. D., Scher I., Campbell G. H., MacDermott R. P., Formal S. B. Susceptibility of CBA/N mice to infection with Salmonella typhimurium: influence of the X-linked gene controlling B lymphocyte function. J Immunol. 1979 Aug;123(2):720–724. [PubMed] [Google Scholar]
  38. Perlmutter R. M., Briles D. E., Davie J. M. Complete sharing of light chain spectrotypes by murine IgM and IgG anti-streptococcal antibodies. J Immunol. 1977 Jun;118(6):2161–2166. [PubMed] [Google Scholar]
  39. Perlmutter R. M., Hansburg D., Briles D. E., Nicolotti R. A., Davie J. M. Subclass restriction of murine anti-carbohydrate antibodies. J Immunol. 1978 Aug;121(2):566–572. [PubMed] [Google Scholar]
  40. Perlmutter R. M., Nahm M., Stein K. E., Slack J., Zitron I., Paul W. E., Davie J. M. Immunoglobulin subclass-specific immunodeficiency in mice with an X-linked B-lymphocyte defect. J Exp Med. 1979 Apr 1;149(4):993–998. doi: 10.1084/jem.149.4.993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Polhill R. B., Jr, Newman S. L., Pruitt K. M., Johnston R. B., Jr Kinetic assessment of alternative complement pathway activity in a hemolytic system. II. Influence of antibody on alternative pathway activation. J Immunol. 1978 Jul;121(1):371–376. [PubMed] [Google Scholar]
  42. Potter M. Antigen-binding myeloma proteins in mice. Ann N Y Acad Sci. 1971 Dec 31;190:306–321. doi: 10.1111/j.1749-6632.1971.tb13543.x. [DOI] [PubMed] [Google Scholar]
  43. Proceedings of Local Branches of the Society of American Bacteriologists. Eastern Pennsylvaniaand New York City Branches. J Bacteriol. 1937 Mar;33(3):335–337. doi: 10.1128/jb.33.3.335-337.1937. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. SCHNEIDER H. A., ZINDER N. D. Nutrition of the host and natural resistance to infection. V. An improved assay employing genetic markers in the double strain inoculation test. J Exp Med. 1956 Feb 1;103(2):207–223. doi: 10.1084/jem.103.2.207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. SMITH M. R., WOOD W. B., Jr Surface phagocytosis; further evidence of its destructive action upon fully encapsulated pneumococci in the absence of type-specific antibody. J Exp Med. 1958 Jan 1;107(1):1–12. doi: 10.1084/jem.107.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Scher I., Ahmed A., Strong D. M., Steinberg A. D., Paul W. E. X-linked B-lymphocyte immune defect in CBA/HN mice. I. Studies of the function and composition of spleen cells. J Exp Med. 1975 Apr 1;141(4):788–803. [PMC free article] [PubMed] [Google Scholar]
  47. Scher I., Steinberg A. D., Berning A. K., Paul W. E. X-linked B-lymphocyte immune defect in CBA/N mice. II. Studies of the mechanisms underlying the immune defect. J Exp Med. 1975 Sep 1;142(3):637–650. doi: 10.1084/jem.142.3.637. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Stein K. E., Brennan C. A., Mond J. J., Mäkelä O., Paul W. E. Antibody affinity in mice with the CBA/N defect. J Immunol. 1980 Apr;124(4):1798–1802. [PubMed] [Google Scholar]
  49. Thompson H. C., Eisenstein T. K. Biological properties of an immunogenic pneumococcal subcellular preparation. Infect Immun. 1976 Mar;13(3):750–757. doi: 10.1128/iai.13.3.750-757.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Tillett W. S. ACTIVE AND PASSIVE IMMUNITY TO PNEUMOCOCCUS INFECTION INDUCED IN RABBITS BY IMMUNIZATION WITH R PNEUMOCOCCI. J Exp Med. 1928 Nov 30;48(6):791–804. doi: 10.1084/jem.48.6.791. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Tillett W. S., Goebel W. F., Avery O. T. CHEMICAL AND IMMUNOLOGICAL PROPERTIES OF A SPECIES-SPECIFIC CARBOHYDRATE OF PNEUMOCOCCI. J Exp Med. 1930 Nov 30;52(6):895–900. doi: 10.1084/jem.52.6.895. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Tillett W. S., Goebel W. F., Avery O. T. CHEMICAL AND IMMUNOLOGICAL PROPERTIES OF A SPECIES-SPECIFIC CARBOHYDRATE OF PNEUMOCOCCI. J Exp Med. 1930 Nov 30;52(6):895–900. doi: 10.1084/jem.52.6.895. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES